A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
160
Participants
Timeline
Start Date
February 29, 2012
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
Conditions
Non-Small -Cell Lung Cancer
Interventions
DRUG
Veliparib
DRUG
Carboplatin
DRUG
paclitaxel
DRUG
placebo
All Listed Sponsors
lead
AbbVie (prior sponsor, Abbott)
INDUSTRY
NCT01560104 - A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter